Pharma

Feb 12, 2016 at 22:23 | Source: CNBC-TV18
"I now the first half of this year has been challenging for us. Q3, you have already started seeing recovery. Q4, you will more so and into the next year, but when I think about the business from the next couple of years' perspective, we are set for growth in the US," Vinita Gupta of Lupin says.
Feb 12, 2016 at 21:18 | Source: PTI
The significant violations included the company's failure "to maintain floors, walls, and ceilings of smooth, hard surfaces that are easily cleanable in aseptic processing areas".
Feb 12, 2016 at 17:17 | Source: Moneycontrol.com
Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 943 in its research report dated Februrary 10, 2016.
Feb 12, 2016 at 17:14 | Source: Moneycontrol.com
Edelweiss is bullish on Torrent Pharma has recommended buy rating on the stock with a target price of Rs 1840 in its research report dated February 4, 2016.
Feb 12, 2016 at 17:05 | Source: Moneycontrol.com
EIS is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 849 in its research report dated February 11, 2016.
Feb 12, 2016 at 16:52 | Source: Moneycontrol.com
Religare has recommended hold rating on Torrent Pharma with a target price of Rs 1560 in its research report dated February 5, 2016.
Feb 12, 2016 at 16:51 | Source: Moneycontrol.com
Axis Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 940 in its research report dated February 11, 2016.
Feb 12, 2016 at 15:59 | Source: Moneycontrol.com
Tata Motors, Bharti Airtel, M&M, Axis Bank and NTPC are top gainers while BHEL, Adani Ports, ONGC, Hindalco and L&T were losers in the Sensex.
Feb 12, 2016 at 15:03 | Source: CNBC-TV18
CNBC-TV18's Reema Tendulkar lists out stocks that you should focus on BHEL, M&M, Adani Ports, Sun Pharma, Punjab National Bank, State Bank of India, ICICI Bank, IndusInd Bank, Vedanta, Tata Motors, TeamLease Services.
Feb 12, 2016 at 14:53 | Source: Moneycontrol.com
Revenue increased 3.6 percent to Rs 7,082 crore in quarter ended December 2015 compared to Rs 6,837.6 crore in preceding quarter.
Messages on Pharma »

subs74

Silver Member

5 Followers

Biocon  

Namo baba, at the end of the day its about fundamentals as also whether stock is in strong hands. pls look at other midcap pharma stocks like cadila, zydus,ipca. They have all gone up even on such a day despite having run up already which means they are in strong hands who dont allow the stocks

4.54 PM Jul 8th 2014

abhishek_co
ssipore

New Member

1 Followers

Dishman Pharma  

Hold Dishman Pharma Targe Price 205

4.48 PM Jul 8th 2014

subs74

Silver Member

5 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th 2014

Ajanta Pharma  

After AGM the share price will shoot up towards benefits to all investers - My target for Ajanta Pharma is Rs 2500 for the long term with a stoploss of Rs 1499

4.30 PM Jul 8th 2014

Ravi_jangra

New Member

0 Follower

Alembic Pharma  

Salute to alembic pharma....All stocks down but alembic not....Guys today see alembic strong unbreakable resistance on 300/-.This is righttime to entre now or never...Save me today from huge lose

4.19 PM Jul 8th 2014

jagoinvesto
r

Platinum Member

123 Followers

Morepen Lab  

morepen to buy sun pharma

4.15 PM Jul 8th 2014

JPInvestor

New Member

0 Follower

SMS Pharma  

my view is that the equity base of SMS Pharma is very small and already having good profit. hence it can easily cross the above figures.

3.55 PM Jul 8th 2014

subs74

Silver Member

5 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th 2014

shmarketgen
ius

Platinum Member

722 Followers

Tech Mahindra  

suggest,that you try & find a small/mid- cap Pharma/IT/Auto Ancillary company or a consumer play.These stories are huuuge in size & will pay rich dividends.

3.47 PM Jul 8th 2014

countryman

Platinum Member

1096 Followers

Granules India  

For solving the problem of CAD, Re cannot go down so much to probably 53 levels which will hurt the exporters. I understand that RBI will control Re between 58 to 61 level so that exporters will get benefitted. Company has expanded their facilities, bought Auctus Pharma and this year Auctus

3.36 PM Jul 8th 2014

News across the web »
Feb 09, 2016 at 23:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.